← All Immunitybio, INC filings

Immunitybio, INC Schedule 13D activist filings

Filed when an investor crosses five percent and intends to influence the company — the activist disclosure.

NASDAQ
IBRX
Immunitybio, INC
SCHEDULE: ImmunityBio: Major Stakeholder Disclosures Revealed
An amended Schedule 13D filing for ImmunityBio, Inc. details substantial beneficial ownership by Patrick Soon-Shiong and affiliated entities, collectively holding a significant portion of the company's common stock.
NASDAQ
IBRX
Immunitybio, INC
SCHEDULE: Soon-Shiong Group Boosts ImmunityBio Stake to 66.3%
Dr. Patrick Soon-Shiong and affiliated entities have increased their beneficial ownership in ImmunityBio, Inc. to 66.3% of outstanding common stock.
NASDAQ
IBRX
Immunitybio, INC
SCHEDULE: ImmunityBio Ownership Update: Soon-Shiong's Stake at 68.9%
An amendment to Schedule 13D details the beneficial ownership of ImmunityBio, Inc. common stock by Patrick Soon-Shiong and affiliated entities, with Dr. Soon-Shiong's aggregate stake reaching 68.9%.